Status:
NOT_YET_RECRUITING
Implementation Research on the Intervention Mode of " Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing
Lead Sponsor:
Capital Medical University
Collaborating Sponsors:
Peking University
Center for Disease Control and Prevention of Bejing Economic-Technoloogical Develeopment Area
Conditions:
Depression
Obesity
Eligibility:
All Genders
Phase:
NA
Brief Summary
Depression and obesity have become the most prominent health problems among adolescents and have caused a heavy burden on the health and social economy of the whole population. There are high incidenc...
Eligibility Criteria
Inclusion
- Stage I (screening stage):
- Middle school students in Beijing Economic-Technological Development Area and other districts of Beijing, both male and female;
- Students themselves and their guardians are willing to participate in this study and sign written informed consent file.
- Stage Ⅱ:
- Middle school students who were identified as high risk of depression and/or obesity in Stage I in Beijing Economic-Technological Development Area and other districts of Beijing, the screening criteria are as follows:
- ① CES-DC score ≥16 points;
- ② BMI ≥WS/T586-2018: Screened as overweight and obesity among school-age children and adolescents, according to the recommendation by the National Health Commission;
- ③ Students themselves and their guardians are willing to participate in this study and provide written informed consent.
Exclusion
- Stage I:
- Having serious physical or genetic disease that is not suitable for participation in the study;
- Have been evaluated that not suitable for this study by investigators.
- Stage Ⅱ:
- Having serious physical or genetic disease that is not suitable for participation in the study;
- Have been evaluated that not suitable for this study by investigators.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT06489990
Start Date
August 1 2024
End Date
December 31 2026
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anding Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100088